CERAMED's OSTEOGRAF CS-300 APPROVABLE BUT SHOULD PROVE SUPERIORITY IN POSTMARKET STUDY, DENTAL PANEL SAYS; PRODUCT ACHIEVES 72% BONE DEFECT FILL RATE

More from Archive

More from Medtech Insight